{
  "slug": "bioptic",
  "name": "Bioptic",
  "description": "BIOPTIC helps pharma teams and investors evaluate drug assets, track competitors, and plan product launches using AI agents that gather and organize evidence, with findings reviewed by pharma experts.",
  "url": "https://optimly.ai/brand/bioptic",
  "websiteUrl": "https://bioptic.io/",
  "logoUrl": "https://logo.clearbit.com/bioptic.io",
  "baiScore": 57.5,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "Biopharma Strategic Intelligence Platforms",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-19T10:30:42.494Z",
  "verifiedVitals": {
    "website": "https://bioptic.io",
    "category": "Pharmaceutical AI",
    "what_it_does": "BIOPTIC helps pharma teams and investors evaluate drug assets, track competitors, and plan product launches by using AI agents to gather and organize evidence, which is then reviewed by pharma experts.",
    "primary_audience": "Pharma teams and investors.",
    "core_product": "An AI-powered platform that combines pharma data sources with AI agents to search in parallel, organize findings, and provide supporting evidence for expert review, delivering structured reports for services like launch planning, asset scouting, competitive intelligence, and due diligence.",
    "pricing_model": {
      "kind": "custom",
      "detail": "Project-based, with scope, deliverables, and timeline agreed upon before work begins."
    }
  },
  "intentTags": {
    "problemIntents": [
      "Inefficient manual competitive intelligence",
      "Lack of global market visibility",
      "Slow time-to-insight for pharma decisions",
      "Risk of human error or AI hallucination in research",
      "Outdated market intelligence reports",
      "Difficulty identifying and evaluating drug candidates",
      "Challenges in comparing GLP-1 development programs",
      "Need for detailed ALS care pathway mapping"
    ],
    "solutionIntents": [
      "AI-driven commercial intelligence for pharma",
      "Real-time global competitive tracking",
      "Accelerated market analysis and insights",
      "Pharma-grade accurate research with expert review",
      "Continuous monitoring of market landscapes",
      "Streamlined launch planning",
      "Efficient asset scouting and in-licensing",
      "Thorough due diligence for drug assets"
    ],
    "evaluationIntents": [
      "AI agent performance benchmarks",
      "Expert human review of AI findings",
      "Multi-model cross-checking for accuracy",
      "Sources from trial registries",
      "Sources from patents",
      "Sources from publications",
      "Sources from company disclosures",
      "Chinese-language source analysis"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1789846505572
}